EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

Diffuse Eruptive Spitz Nevus With Somatic TPM3 :: ALK Fusion Confirmed Across Anatomically Distinct Lesions

Bengu Nisa Akay iD, Handan Merve Erol Mart iD, Sule Altiner iD, Devrim Deniz Kuscu iD, Aylin Okcu Heper iD

Pigment Cell & Melanoma Research · 2026

DOI: 10.1111/pcmr.70122 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pigment Cell & Melanoma Research, 2026. Verfasst von Bengu Nisa Akay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Ankara University, Ankara, Turkey. Hauptthemen laut MEDLINE: Nevus, Epithelioid and Spindle Cell, Tropomyosin, Skin Neoplasms, Anaplastic Lymphoma Kinase. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eruptive disseminated Spitz nevus (EDSN) is an exceptionally rare condition characterized by widespread Spitz‐spectrum melanocytic lesions. We report a 21‐year‐old woman with an estimated 50,000–60,000 lesions involving the entire cutaneous surface, predominantly the trunk and proximal extremities. Lesions began at age 17 with hundreds of lesions and increased dramatically over subsequent years. Initial HRAS sequencing and ROS1 FISH were negative; broader molecular profiling was performed at re‐presentation. Seven representative lesions from distinct sites were sampled: five Spitz nevi and two atypical Spitz tumors, without melanoma. Strong, diffuse ALK expression was detected in three lesions, while RNA sequencing identified an identical TPM3 exon 8::ALK exon 20 fusion in two of seven lesions from anatomically separate sites. Although compatible with shared clonality, this finding does not establish a common clonal origin because TPM3::ALK is a recurrent Spitz driver and transcript‐level concordance does not prove an identical genomic breakpoint. A constitutional NF1 p.S1249F variant was classified as a variant of uncertain significance and was also present in two clinically unaffected brothers, arguing against an independently sufficient pathogenic role. TPM3::ALK remains the only demonstrated oncogenic driver. To our knowledge, this represents the first longitudinal molecular follow‐up of EDSN, with findings compatible with either clonal dissemination or recurrent independent acquisition of the same driver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nevus, Epithelioid and Spindle CellTropomyosinSkin NeoplasmsAnaplastic Lymphoma KinaseOncogene Proteins, FusionHumansFemaleYoung Adult

Stichwörter der Autor:innen

Spitz neoplasmTPM3::ALK fusioneruptive disseminated Spitz nevusmolecular pathologyneurofibromatosis type 1

Substanzen

TropomyosinTPM3 protein, humanAnaplastic Lymphoma KinaseOncogene Proteins, FusionALK protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Department of Medical Biology and Genetics, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Department of Dermatology, Cihanbeyli State Hospital, Konya, Turkey.
  • Department of Pathology, Faculty of Medicine, Ankara University, Ankara, Turkey.

ORCID-Profile: Bengu Nisa Akay, Handan Merve Erol Mart, Sule Altiner, Devrim Deniz Kuscu, Aylin Okcu Heper

Zitieren

APA

Akay, B. N., Mart, H. M. E., Altiner, S., Kuscu, D. D., & Heper, A. O. (2026). Diffuse Eruptive Spitz Nevus With Somatic TPM3 :: ALK Fusion Confirmed Across Anatomically Distinct Lesions. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.70122

Vancouver

Akay BN, Mart HME, Altiner S, Kuscu DD, Heper AO. Diffuse Eruptive Spitz Nevus With Somatic TPM3 :: ALK Fusion Confirmed Across Anatomically Distinct Lesions. Pigment Cell & Melanoma Research. 2026. doi:10.1111/pcmr.70122

BibTeX
@article{Akay2026,
  author = {Akay, Bengu Nisa and Mart, Handan Merve Erol and Altiner, Sule and Kuscu, Devrim Deniz and Heper, Aylin Okcu},
  title = {Diffuse Eruptive Spitz Nevus With Somatic TPM3 :: ALK Fusion Confirmed Across Anatomically Distinct Lesions},
  journal = {Pigment Cell & Melanoma Research},
  year = {2026},
  doi = {10.1111/pcmr.70122}
}
Kostenlos starten →